Regulatory approval

Oral GLP-1 drugs could widen access, but high prices may do the opposite

China Just Put a Bispecific ADC Into Esophageal Cancer

India Approved Its First Dengue Vaccine. Access Is Still Unwritten.

Tissue-Agnostic Medicine Has a New Proof Point

Breast Cancer Gets a New PI3K Pathway Option.

Bladder Cancer Surgery Just Became a System Test

Alzheimer’s Treatment Moves Home. Risk Does Not.

Desmoid Tumours Are Not Benign to the People Living With Them

Pancreatic Cancer Is Forcing Regulators to Move Faster
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
